Reading between the lines in the MD&A 1Q26: Humanica Public Company Limited (HUMAN)
Reading between the lines in the 1Q26 Management Discussion and Analysis of Humanica Public Company Limited (HUMAN): Revenue up 15.9%. Net profit down 3.5%. And the lead profitability metric from FY25 does not appear in 1Q26.
The numbers
Revenue accelerates as new subsidiaries reach full run-rate
Humanica provides HR management software, payroll outsourcing, and ERP solutions across Southeast Asia. In 1Q26, revenue rose 15.9% YoY to Bt403m, with both segments contributing: HR Solutions +14.2% and Financial Solutions +33.6%. Part of the acceleration reflects the first full quarter of contribution from two acquisitions made in 2025, Cadena (from August 2025) and Humanica ERP (from October 2025).
Costs outpace revenue; gross margin falls to its lowest recent level
Gross margin compressed to 46.1% in 1Q26 from 49.7% in 1Q25, as cost of sales rose 24.3% against revenue growth of 15.9%. The main drivers were staff costs (+Bt26m) and cloud costs (+Bt7m). Net profit fell 3.5% to Bt78m, a net margin of 19.3% against 23.1% in 1Q25.
Goodwill and cash drive assets higher
Total assets rose 4.1% to Bt4,081m from Bt3,921m at FY25, with the two main drivers being a Bt72m increase in goodwill from foreign exchange revaluation of the DataOn and Cadena goodwill balances, and a Bt63m rise in cash and cash equivalents.
What the numbers don’t show
Comparing the FY25 MD&A with 1Q26, a couple of things stand out.
The Adjusted EBT metric that led the FY25 discussion is absent from 1Q26
In the FY25 MD&A, Adjusted EBT was the primary profitability metric, presented as a dedicated row in the financial summary table, positioned between gross profit and EBT, and defined in a footnote as earnings before tax, excluding FX gains and losses, share-based payment effects, one-off items, and PPA amortization from acquisitions. FY25 Adjusted EBT was Bt460m, and the filing used it to separate underlying business performance from accounting adjustments. The 1Q26 MD&A presents only EBT and net profit. One item worth noting: the FY25 MD&A recorded a reversal of share-based payment expenses of +Bt8.67m as a positive EBT item. In 1Q26, an identical figure, -Bt8.67m, appears as a negative component of SG&A. Neither filing explains the circumstances that produced first a reversal and then a re-charge of the identical figure.
Financial Solutions swung to an operating loss with no cost explanation
The FY25 MD&A highlighted Financial Solutions as the faster-growing segment, with operating profit rising 41.0% to Bt42m and gross margin expanding. In 1Q26, Financial Solutions revenue grew by 33.6%, but the segment recorded an operating loss of Bt0.25m, compared with an operating profit of Bt5.68m in 1Q25. Gross profit fell Bt0.14m despite revenue rising Bt11m, meaning costs rose by roughly the same amount as revenue. The 1Q26 MD&A discloses the segment figures but does not explain why costs rose so sharply in Financial Solutions relative to its revenue growth.